Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia.
Pesce
A
A
Department of Internal Medicine and Hematology, Cimiez Hospital, Nice, France.
Filippi
C
C
Rosenthal
E
E
Taillan
B
B
Garnier
G
G
Vinti
H
H
Gratecos
N
N
Poitou
G
G
Garbe
L
L
Michiels
J F
JF
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D006086:Graft vs Host Disease / Q000517:prevention & control; D018219:Histiocytoma, Benign Fibrous / Q000000981:diagnostic imaging / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011859:Radiography
D000903:Antibiotics, Antineoplastic; D003561:Cytarabine; C002205:zorubicin; D008727:Methotrexate; D003630:Daunorubicin